BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12757973)

  • 21. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
    Min J; Wright WE; Shay JW
    Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof.
    Claude E; Decottignies A
    Curr Opin Genet Dev; 2020 Feb; 60():1-8. PubMed ID: 32114293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of telomerase induces alternative lengthening of telomeres during human esophageal carcinogenesis.
    Queisser A; Heeg S; Thaler M; von Werder A; Opitz OG
    Cancer Genet; 2013 Nov; 206(11):374-86. PubMed ID: 24331919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ALT--alternative lengthening of telomere].
    Wu XM; Tang WR; Luo Y
    Yi Chuan; 2009 Dec; 31(12):1185-91. PubMed ID: 20042385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of telomere-binding proteins in carcinogenesis].
    Aragona M; Pontoriero A; Panetta S; La Torre I; La Torre F
    Minerva Med; 2000; 91(11-12):299-304. PubMed ID: 11253711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative lengthening of telomeres in mammalian cells.
    Henson JD; Neumann AA; Yeager TR; Reddel RR
    Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase inhibition alters telomere maintenance mechanisms in laryngeal squamous carcinoma cells.
    Chen W; Chen SM; Yu Y; Xiao BK; Huang ZW; Tao ZZ
    J Laryngol Otol; 2010 Jul; 124(7):778-83. PubMed ID: 20403221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
    Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
    Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomere lengthening in telomerase-negative cells: the ends are coming together.
    Scheel C; Poremba C
    Virchows Arch; 2002 Jun; 440(6):573-82. PubMed ID: 12070595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
    De Vitis M; Berardinelli F; Sgura A
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomere-driven genomic instability in cancer cells.
    Desmaze C; Soria JC; Freulet-Marrière MA; Mathieu N; Sabatier L
    Cancer Lett; 2003 May; 194(2):173-82. PubMed ID: 12757975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
    Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
    J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomeres and chromosomal instability.
    Mathieu N; Pirzio L; Freulet-Marrière MA; Desmaze C; Sabatier L
    Cell Mol Life Sci; 2004 Mar; 61(6):641-56. PubMed ID: 15052408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.
    Gao J; Pickett HA
    Nat Rev Cancer; 2022 Sep; 22(9):515-532. PubMed ID: 35790854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
    Nittis T; Guittat L; Stewart SA
    Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immortalized cells with no detectable telomerase activity. A review.
    Reddel RR; Bryan TM; Murnane JP
    Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
    Atkinson SP; Hoare SF; Glasspool RM; Keith WN
    Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
    Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
    J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter.
    Hoare SF; Bryce LA; Wisman GB; Burns S; Going JJ; van der Zee AG; Keith WN
    Cancer Res; 2001 Jan; 61(1):27-32. PubMed ID: 11196173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomeres: Implications for Cancer Development.
    Bernal A; Tusell L
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.